Analyst Ratings For NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)
Today, JPMorgan Chase initiated coverage on NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA) with a Overweight.
Some recent analyst ratings include
- 4/10/2018-JPMorgan Chase initiated coverage with a Overweight rating.
- 4/6/2018-William Blair Reiterated Rating of Buy.
- 3/15/2018-Guggenheim initiated coverage with a Neutral rating.
- 3/13/2018-Canaccord Genuity Reiterated Rating of Buy.
- 2/28/2018-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ” rating to a ” Market Perform” rating.
- 2/15/2018-Citigroup was Downgraded by analysts at Citigroup from a “Neutral ” rating to a ” Sell” rating.
Recent Insider Trading Activity For NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)
NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 76.88%.
- On 3/29/2018 Mitchall G Clark, EVP, sold 22,400 with an average share price of $40.07 per share and the total transaction amounting to $897,568.00.
- On 3/26/2018 Christopher Haqq, EVP, sold 18,327 with an average share price of $39.79 per share and the total transaction amounting to $729,231.33.
- On 3/26/2018 Isaac E Ciechanover, CEO, sold 4,400 with an average share price of $40.10 per share and the total transaction amounting to $176,440.00.
- On 3/20/2018 John Mcgrath, CFO, sold 6,000 with an average share price of $40.41 per share and the total transaction amounting to $242,460.00.
- On 3/16/2018 Isaac E Ciechanover, CEO, sold 8,800 with an average share price of $42.13 per share and the total transaction amounting to $370,744.00.
- On 3/12/2018 Isaac E Ciechanover, CEO, sold 1,000 with an average share price of $46.31 per share and the total transaction amounting to $46,310.00.
- On 2/22/2018 Isaac E Ciechanover, CEO, sold 17,800 with an average share price of $44.65 per share and the total transaction amounting to $794,770.00.
Recent Trading Activity for NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)
Shares of NASDAQ:ATRA – Atara Biotherapeutics closed the previous trading session at 38.10 up +2.10 5.83% with shares trading hands.